SOCIETY

Vaccine Development

The COVID-19 vaccine workshop of the China National Pharmaceutical Group (Sinopharm) on April 10. Developed by the Wuhan Institute of Biological Products under Sinopharm and the Wuhan Institute of Virology under the Chinese Academy of Sciences, the vaccine was approved for clinical trial on April 12. Another vaccine developed by Sinovac Research and Development, a company based in Beijing, was approved for trial on April 13.

COVID-19 Survey

To track asymptomatic cases of the novel coronavirus disease (COVID-19), Wuhan, the hardest-hit city in China, launched an epidemiological sample survey of local residents on April 14.

The survey started in Jiangxia District where 880 residents received free nucleic acid and antibody tests.

The survey will cover 11,000 residents in 13 districts. To ensure data accuracy,